ABCL·00288U106·US·equity·Healthcare - Biotechnology-13D/G
ABCL (ABCELLERA BIOLOGICS INC) is held by 77 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($105.7M), Capital World Investors ($46.6M), TWO SIGMA INVESTMENTS, LP ($36.9M). Net institutional sentiment: Mixed.
See how ABCL's score breaks down across 4 SEC sources
Showing 1-20 of 91
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer